Biologic Drugs With Mechanism of Action: Interleukin 2 Receptor Antagonists
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Biologic Drugs With Mechanism of Action: Interleukin 2 Receptor Antagonists
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Novartis Pharmaceuticals Corporation | SIMULECT | basiliximab | For Injection | 103764 | 1998-05-12 | See Plans and Pricing | See Plans and Pricing |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Patent Expiration |